NewsSite News Research shows progress toward a genital herpes vaccineMore than 8,000 women participated in the NIH-funded study, which was conducted in part at UNC. The vaccine was partially effective at preventing herpes simplex virus type 1 (HSV-1), but did not protect women from herpes simplex virus type 2 (HSV-2). First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 monthsThe University of North Carolina at Chapel Hill enrolled 1,600 children at the study site in Lilongwe, Malawi. Distinct AIDS viruses found in cerebrospinal fluid of people with HIV dementiaThis is the first study to demonstrate active replication of HIV virus in a cell type other than immune T cells and which may help to predict patients at greatest risk for HIV dementia. New study adds further guidance on when to start antiretroviral therapy for HIVA new study led by researchers at the University of North Carolina at Chapel Hill finds that there may be a limit to how early the therapy, known as HAART, should start. Center for AIDS Research federal funding extended through 2016The UNC Center for AIDS Research (CFAR) plays an active role in education and outreach, and provides developmental grant awards to support new ideas and new investigators in HIV/AIDS research. As HIV treatment improves, “trial effect” is diminished, new study suggestsJuly 13, 2011 – A new study by investigators from the University of North Carolina at Chapel Hill School of Medicine has confirmed the existence of a “trial effect” in clinical trials for treatment of HIV and also shows that effect has diminished over time. UNC tapped to lead national effort to find a cure for AIDSJuly 11, 2011 -- Researchers at the University of North Carolina at Chapel Hill have been awarded a $32 million, five-year federal grant to develop ways to cure people with HIV by purging the virus hiding in the immune systems of patients taking antiretroviral therapy. Tackling this latent virus is considered key to a cure for AIDS. Adimora appointed to NIAID Advisory CouncilJuly 8, 2011 – Adaora Adimora, MD, MPH, professor of medicine in the Division of Infectious Diseases in the Department of Medicine at UNC, has been appointed to the Advisory Council of the National Institute of Allergy and Infectious Diseases. Acute Hepatitis A evades immune system more effectively than chronic cousinIn comparing data from experiments with Hepatitis A and Hepatitis C, the research team found that Hepatitis A virus, which causes only acute, self-limited disease, is more efficient at inhibiting the host’s interferon response, and that the virus can actually linger in the body for almost a year. UNC researchers earn prestigious Charles C. Shepard AwardUNC researchers have been awarded the prestigious Charles C. Shepard Science Award in the category of Prevention and Control by the Centers for Disease Control and Prevention for their paper titled, “Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.” Preventing the spread of HIV/AIDS with humanized BLT miceA new study from the University of North Carolina at Chapel Hill School of Medicine further validates the use of humanized BLT mice in the fight to block HIV transmission. UNC-led international study shows early treatment with antiretroviral therapy prevents HIV transmissionA research study led by the University of North Carolina at Chapel Hill has made a major discovery in the effort to halt the spread of HIV, the virus that causes AIDS. New public-private partnership will improve health care delivery at more than 130 clinics in MalawiThe USAID-funded Lilongwe Relief Fund Trust of Malawi (LMRFT), in collaboration with the University of North Carolina (UNC) at Chapel Hill and several other public and private partners, has begun implementing the Safeguard the Family Project, which is aimed at decreasing mother-to-child transmission of HIV and reducing maternal and infant mortality. UNC faculty, trainees presented in record numbers at CROI 2011The 18th Annual Conference on Retroviruses and Opportunistic Infections (CROI) wrapped up in Boston, Massachusetts, earlier this month, and UNC had a strong presence at this year’s conference. School of Medicine uses mobile health clinic to serve hard-to-reach populations, improve researchThe University of North Carolina at Chapel Hill School of Medicine has launched a new program which will expand both the research and clinical capabilities of the University. UNC researchers Jeff Dangl, PhD, and P. Frederick Sparling, MD, have been named fellows of the American Academy of MicrobiologyFellows are elected in recognition of excellence, originality and creativity in the microbiological sciences, and have built exemplary careers in basic and applied research, teaching, clinical and public health, industry or government service. |
|
Related institutional links
Loading
